New Research: Duavee's Emerging Role in Breast Cancer Risk Reduction

For many women, managing menopause can feel like balancing bothersome symptoms with concerns about long-term health risks—especially breast cancer. One of the most misunderstood areas is the relationship between menopause hormone therapy (MHT) and breast cancer. Much of the fear surrounding hormone therapy stems from early misinterpretations of the Women's Health Initiative (WHI) study. Although the WHI raised valid concerns, later analysis has shown that risks were often overstated and do not apply equally to all women or all forms of MHT. Notably, the WHI’s estrogen-only arm (specifically conjugated equine estrogens, or CEE) was associated with a reduction in both breast cancer incidence and mortality.

Want to read more?

Subscribe to purelymenopause.com to keep reading this exclusive post.

Subscribe Now